Home NDC 65862-096-26 CEFPODOXIME PROXETIL
Product NDC 65862-096
Requested package NDC 65862-096-26
11-digit product format 658620096
Labeler code 65862
Product ID 65862-096_12ee6554-adfc-4c3b-b87e-3568576359a6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CEFPODOXIME PROXETIL
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA065370
Marketing category ANDA
Marketing start 2007-06-11
Substance CEFPODOXIME PROXETIL
Active strength 200 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 4184dd79f89f…545327b3e20f…2020-06-10 20:45 UTC · source 2020-06-10 4bd3596a7b87…5c64c6f6865f…2019-12-08 06:16 UTC · source 2019-12-05 263afe128892…91768de4ddbe…2019-06-01 22:24 UTC · source 2019-05-30 5b2001dcd8f5…54b53d4dc9e4…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065370-001 CEFPODOXIME PROXETIL CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 A065370-002 CEFPODOXIME PROXETIL CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065370-001 CEFPODOXIME PROXETIL EQ 100MG BASE TABLET / ORAL AB 2007-06-11 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A065370-002 CEFPODOXIME PROXETIL EQ 200MG BASE TABLET / ORAL AB 2007-06-11 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
Additional Listing Data#
Finished product Yes
Brand name base CEFPODOXIME PROXETIL
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEFPODOXIME PROXETIL 200 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2TB00A1Z7N Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 309076 Internal RxNorm lookup 309078 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65862-096-01 CEFPODOXIME PROXETIL 100 in 1 BOTTLE TABLET, FILM COATED 100 12 65862-096-20 CEFPODOXIME PROXETIL 20 in 1 BOTTLE TABLET, FILM COATED 20 12 65862-096-25 CEFPODOXIME PROXETIL 250 in 1 BOTTLE TABLET, FILM COATED 250 12 65862-096-99 CEFPODOXIME PROXETIL 1000 in 1 BOTTLE TABLET, FILM COATED 1000 12
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEFPODOXIME PROXETIL ACTIVE INGREDIENT 2TB00A1Z7N CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 CEFPODOXIME ACTIVE MOIETY 7R4F94TVGY CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 CARBOXYMETHYLCELLULOSE CALCIUM INACTIVE INGREDIENT UTY7PDF93L CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 5 CEFPODOXIME PROXETIL ACTIVE INGREDIENT 2TB00A1Z7N CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 CEFPODOXIME ACTIVE MOIETY 7R4F94TVGY CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 CARBOXYMETHYLCELLULOSE CALCIUM INACTIVE INGREDIENT UTY7PDF93L CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65862-096 CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 12 Current NDC, Legacy NDC, 4 package rows 20240104_c36f2137-98bb-4583-89f7-6bce9582c465.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Status 65862-096-26 65862009626 2500 TABLET, FILM COATED in 1 BAG (65862-096-26) 11-JUN-07 Current